T Hasegawa (4958) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
26 Oct, 2026Executive summary
Q1 FY2025 net sales rose 7.5% YoY to ¥17,643 million; operating profit increased 4.0% to ¥1,901 million and profit attributable to owners of parent rose 9.8% to ¥1,461 million.
Ordinary profit grew 23.4% to ¥2,288 million, supported by ¥243 million in foreign-exchange gains versus ¥98 million in foreign-exchange losses a year earlier.
Financial highlights
Gross profit was ¥7,416 million versus ¥6,691 million YoY; SG&A was ¥5,514 million versus ¥4,862 million.
EPS was ¥35.65 versus ¥32.35 YoY; diluted EPS was ¥35.49 versus ¥32.22.
Comprehensive income was ¥6,275 million versus a loss of ¥1,069 million, including ¥5,233 million in positive foreign-currency translation adjustments.
Total assets were ¥146,902 million and net assets ¥123,371 million at Dec. 31, 2024, versus ¥144,504 million and ¥119,681 million at Sept. 30, 2024.
Outlook and guidance
FY2025 guidance is unchanged: net sales ¥74,300 million (+3.7% YoY), operating profit ¥9,970 million (+6.9%), ordinary profit ¥10,450 million (+7.5%), and parent-attributable profit ¥7,580 million (+5.2%).
FY2025 EPS forecast is ¥184.84; no revision to the consolidated forecast was made.
Latest events from T Hasegawa
- Sales and profits advanced as overseas growth and the Vietnam acquisition supported results.4958
Q4 2026 - Sales and operating profit rose; full-year guidance was unchanged.4958
Q1 2024 - H1 sales and operating profit grew, led by flavors and stronger Asia and USA results.4958
Q2 2024 - Record FY2024 sales and profit growth underpin further expansion and FY2025 growth.4958
Q4 2024 - Nine-month sales and operating profit rose; FY outlook and dividend were revised.4958
Q3 2024 - Asia-led growth lifted H1 sales and profit, while the USA segment swung to a loss.4958
Q2 2025 - Sales grew, but profit fell; Asia strength offset a U.S. segment loss.4958
Q3 2025 - FY2025 sales grew as profits fell; FY2026 guidance targets recovery and a ¥100 dividend.4958
Q4 2025 - H1 sales rose 4.9%, operating profit edged up 0.2%, and FY2026 guidance was unchanged.4958
Q2 2026